Bhola Rahul, Keech Ronald V, Olson Richard J, Petersen David B
Department of Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52246, USA.
J AAPOS. 2006 Jun;10(3):243-8. doi: 10.1016/j.jaapos.2006.01.005.
To determine the long-term outcome in pediatric patients with aphakic glaucoma.
A retrospective analysis of 130 patients diagnosed with aphakic glaucoma between 1969 and 2004 was performed. A total of 36 patients (55 eyes) were included in this study after excluding those who had cataract extraction after age 10 and those patients with other ocular conditions, systemic syndromes, traumatic cataracts, congenital glaucoma, or inadequate follow-up (less than 1 year). Outcome variables studied included visual acuity, number of medication changes required over the course of the follow-up, maximum number of medications used at a time for more than 6 months to control intraocular pressures, and surgical interventions required. Mean follow-up period was 18.7 years (range, 6.9-35 years).
At the time of last follow-up, 54.5% of the patients had visual acuity 20/40 or better, 34.5% had 20/50 to 20/200, and 11% had acuity worse than 20/200. During the course of follow-up, 34% required 1 to 2 medication changes for controlling glaucoma, 33% required 3 to 5 medication changes, and 33% required 6 or more medication changes. Thirty-six percent of the eyes required a maximum of 1 to 2 medications for more than 6 months during the course of follow-up, 33% required 3, and 31% required 4 or more medications for controlling intraocular pressure. Of the 55 eyes, 15 eyes (27%) required surgical intervention. Six of the 15 eyes (40%) required 1 surgery, 8 eyes (53%) required 2 to 3 surgeries, and 1 eye (7%) required 4 to 6 surgeries.
Patients with glaucoma after pediatric cataract surgery can have a good visual outcome although multiple medications and surgical interventions may be required to control the glaucoma.
确定儿童无晶状体性青光眼患者的长期预后。
对1969年至2004年间诊断为无晶状体性青光眼的130例患者进行回顾性分析。排除10岁后行白内障摘除术的患者以及患有其他眼部疾病、全身综合征、外伤性白内障、先天性青光眼或随访不足(少于1年)的患者后,本研究共纳入36例患者(55只眼)。研究的预后变量包括视力、随访期间所需的药物调整次数、为控制眼压一次使用超过6个月的最大药物数量以及所需的手术干预。平均随访期为18.7年(范围6.9 - 35年)。
在最后一次随访时,54.5%的患者视力为20/40或更好,34.5%的患者视力为20/50至20/200,11%的患者视力低于20/200。在随访期间,34%的患者为控制青光眼需要1至2次药物调整,33%的患者需要3至5次药物调整,33%的患者需要6次或更多次药物调整。随访期间,36%的眼睛为控制眼压一次使用超过6个月的最大药物数量为1至2种,33%的眼睛需要3种,31%的眼睛需要4种或更多种药物。在55只眼中,15只眼(27%)需要手术干预。15只眼中的6只眼(40%)需要1次手术,8只眼(53%)需要2至3次手术,1只眼(7%)需要4至6次手术。
儿童白内障手术后的青光眼患者尽管可能需要多种药物和手术干预来控制青光眼,但仍可获得良好的视力预后。